Hematologic Diseases: Molecular Insights and Novel Methods
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 July 2025 | Viewed by 2390
Special Issue Editors
Interests: hematology; mutation analysis; leukemias
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Novel technologies and tools like single-cell DNA, RNA and protein sequencing (or combinations thereof), spatial omics, 3D genomics, etc. are greatly empowering the way we can investigate the biology of hematologic malignancies, deep diving into their complexity with unprecedented resolution. This enables to better dissect disease pathogenesis, to uncover novel mechanisms of resistance to targeted agents and immunotherapies, to identify therapeutic targets and to enable the implementation of novel algorithms of risk stratification and prognostication. Routine diagnostics is also undergoing a deep technological revolution, with next-generation sequencing, digital PCR, next-generation flow cytometry and other novel tools supplanting the traditional methods of genetic and genomic characterization and measurable residual disease monitoring. We encourage you to submit your research manuscripts and reviews dealing with exciting new advances in the molecular characterization and molecular testing of hematologic malignancies to this Special Issue.
Dr. Simona Soverini
Dr. Samantha Bruno
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic malignancies
- high-throughput technologies
- omics data
- biomarkers
- drug resistance
- minimal residual disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
